Skip to main content
BIO-BBio-Rad Laboratories, Inc.Sell4.7·$306.55+14.63%
BIO-B · Why this verdict

Why Bio-Rad Laboratories (BIO-B) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score4.7/10
ConfidenceMEDIUM
MacroNEUTRAL

Per-dimension breakdown

Value

4.0/10data confidence 60%
ComponentSub-score
P/E2.5
P/S8.2
EV/EBITDA1.2

Quality

5.6/10data confidence 100%
ComponentSub-score
ROE0.8
ROA1.2
Gross margin6.4
Op margin2.3
Net margin3.3
Current ratio9.8
FCF quality9.5
Moat6.8
Piotroski F10.0
  • Excellent cash conversion: 136% FCF/NI
  • Strong Piotroski F-Score: 9/9

Growth

2.8/10data confidence 33%
ComponentSub-score
Rev growth2.8

Momentum

6.9/10data confidence 100%
ComponentSub-score
RSI3.0
MACD10.0
OBV5.5
MA position9.0
  • Overbought (RSI 100)
  • Above 200-day MA

Sentiment

4.6/10data confidence 67%
ComponentSub-score
Analyst rating5.0
erm sentiment3.9

Insider

5.0/10data confidence 50%

Peer rank

1.9/10data confidence 80%
ComponentSub-score
value rank2.7
quality rank3.7
growth rank1.3

Technical

4.0/10data confidence 100%
ComponentSub-score
bollinger3.2
support resistance0.0
52w position8.9

Risk (lower is worse)

9.2/10data confidence 100%
ComponentSub-score
short interest10.0
days to cover10.0
volatility10.0
beta6.7
debt equity9.2

Catalyst

6.2/10data confidence 75%
ComponentSub-score
erm2.5
earnings history6.7
surprise avg9.4
  • Strong earnings: 3B/1M

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (7)
  • MOMENTUM:6.9>=5.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:NO_DATE
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)

none

Warning (1)
  • ASYMMETRY:UPSIDE_EXHAUSTED (upside=0.0%)
Reward-to-Risk
0.00
Upside
+0.0%
Downside
15.0%
Sizing output
AVOID

SetupRECOVERY Death cross but MACD improving, RSI 100

EdgeNO_EDGE No clear edge identified

SuitabilityMODERATE Balanced profile

Investment implication

The F-path SELL output reflects an overall score of 4.7 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Risk (lower is worse) at 9.2) was not enough to lift the adjusted overall above the threshold. Current asymmetry R:R is 0.00 — supplementary context, not the trigger for this path.

The strongest dimensions are Risk (lower is worse) at 9.2, Momentum at 6.9, and Catalyst at 6.2; the weakest are Peer rank at 1.9, Growth at 2.8, and Technical at 4.0. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 0.00 and an engine sizing output of AVOID.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks BIO-B Why this verdict